Your browser doesn't support javascript.
loading
Genetically confirmed coexistence of neurofibromatosis type 1 and Cherubism in a pediatric patient.
Sarantou, Sofia; Marinakis, Nikolaos M; Traeger-Synodinos, Joanne; Siomou, Ekaterini; Ntinopoulos, Argyrios; Serbis, Anastasios.
Afiliação
  • Sarantou S; Medical School, University of Ioannina, Ioannina, Greece.
  • Marinakis NM; Laboratory of Medical Genetics, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Traeger-Synodinos J; Laboratory of Medical Genetics, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Siomou E; Department of Pediatrics, School of Medicine, University of Ioannina, St. Niarchos Av, Ioannina, 45100, Greece.
  • Ntinopoulos A; Department of Pediatrics, School of Medicine, University of Ioannina, St. Niarchos Av, Ioannina, 45100, Greece.
  • Serbis A; Department of Pediatrics, School of Medicine, University of Ioannina, St. Niarchos Av, Ioannina, 45100, Greece. aserbis@uoi.gr.
Mol Biol Rep ; 51(1): 216, 2024 Jan 28.
Article em En | MEDLINE | ID: mdl-38281202
ABSTRACT

BACKGROUND:

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder typified by various combination of numerous Café-au-lait macules, cutaneous and plexiform neurofibromas, freckling of inguinal or axillary region, optic glioma, Lisch nodules and osseous lesions. Cherubism is a rare genetic syndrome described by progressive swelling of the lower and/or upper jaw due to replacement of bone by fibrous connective tissue. Patients are reported in the literature with NF1 and cherubism-like phenotype due to the NF1 osseous lesions in the jaws. The purpose of this case report is the description of a young male genetically diagnosed with both NF1 and cherubism. METHODS AND

RESULTS:

A 9 years and six month old patient with clinical findings of NF1 and cherubism in whom both diseases were genetically confirmed, is presented. The patient was evaluated by a pediatrician, a pediatric endocrinologist, an ophthalmologist, and an oral and maxillofacial surgeon. A laboratory and hormonal screening, a histological examination, a chest X-ray, a magnetic resonance imaging (MRI) of the orbit and a digital panoramic radiography were performed. Genetic testing applying Whole Exome Sequencing was conducted.

CONCLUSIONS:

A novel and an already reported pathogenic variants were detected in NF1 and SH3BP2 genes, respectively. This is the first described patient with coexistence of NF1 and cherubism. The contribution of Next Generation Sequencing (NGS) in gene variant identification as well as the importance of close collaboration between laboratory scientists and clinicians, is highlighted. Both are essential for optimizing the diagnostic approach of patients with a complex phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Querubismo / Neurofibromatose 1 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans / Male Idioma: En Revista: Mol Biol Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Querubismo / Neurofibromatose 1 Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans / Male Idioma: En Revista: Mol Biol Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia